Safety flags, transparency gaps, dosing concerns, and recurring buyer complaints.
Safety signals
Drug interaction risk — berberine
Berberine inhibits CYP3A4, CYP2D6, and CYP2C9 even at moderate doses. Documented interactions with immunosuppressants, statins, anticoagulants, and antidiabetic drugs. Consult a physician if taking prescription medications.
Read more
Safety flag
berberine: CYP3A4 interactions
Dose or interaction risk detected. See ingredient page for details.
No public lab certificate
Certificate of Analysis not published
Without a public lab certificate, batch purity and potency cannot be independently verified.
No third-party testing
Independent lab verification not disclosed
The brand does not publish evidence of independent batch testing.
Low transparency
3.0/10 quality transparency
Limited public information about sourcing, testing, or manufacturing.